by jtcir-auto | May 12, 2026 | Press Releases
TORONTO, ONTARIO, May 12, 2026 (GLOBE NEWSWIRE) — COSCIENS Biopharma Inc. (TSX: CSCI) (OTCQB: CSCIF) (“COSCIENS” or the “Company”) today reported its financial and operating results for the first quarter ended March 31, 2026. All amounts...
by jtcir-auto | Apr 20, 2026 | Press Releases
TORONTO, ONTARIO, April 20, 2026 (GLOBE NEWSWIRE) — COSCIENS Biopharma Inc. (TSX: CSCI) (OTCQB: CSCIF) (“COSCIENS” or the “Company”) announced today that it has filed a Rule 13e-3 Transaction Statement (the “Transaction...
by jtcir-auto | Apr 7, 2026 | Press Releases
TORONTO, ONTARIO, April 07, 2026 (GLOBE NEWSWIRE) — COSCIENS Biopharma Inc. (TSX: CSCI) (OTCQB: CSCIF) (“COSCIENS” or the “Company”) is issuing this news release in response to unusual market activity. While the Company does not normally...
by jtcir-auto | Mar 25, 2026 | Press Releases
TORONTO, ONTARIO, March 25, 2026 (GLOBE NEWSWIRE) — COSCIENS Biopharma Inc. (TSX: CSCI) (OTCQB: CSCIF) (“COSCIENS” or the “Company”), a life science company focused on the development of natural, plant-based active ingredients, today...
by jtcir-auto | Mar 5, 2026 | Press Releases
TORONTO, ONTARIO, March 05, 2026 (GLOBE NEWSWIRE) — COSCIENS Biopharma Inc. (TSX: CSCI) (FINRA: CSCIF) (“COSCIENS” or the “Company”) today announced that the Company has made a strategic decision to cease funding its German subsidiaries,...
by jtcir-auto | Dec 1, 2025 | Press Releases
TORONTO, ONTARIO, Dec. 01, 2025 (GLOBE NEWSWIRE) — COSCIENS Biopharma Inc. (TSX: CSCI) (FINRA: CSCIF) (“COSCIENS” or the “Company”), a life sciences company focused on pharmaceutical therapies, diagnostic products, and natural ingredients...
